Kainos Group plc Total Voting Rights (6453V)
July 24 2018 - 12:41PM
UK Regulatory
TIDMKNOS
RNS Number : 6453V
Kainos Group plc
24 July 2018
24 July 2018
Kainos Group plc
("Kainos" or the "Company)
Total Voting Rights
Pursuant to DTR 5.6.1 the Company announces that the as at 24
July 2018, the total number of ordinary shares in issue now stands
at 118,982,942 each with voting rights. There are no shares held in
treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change in their interest
in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
Kainos Group Limited Legal Entity Identifier:
213800H2PQMIF3OVZY47
Classification: Total number of voting rights and capital
Ends
For further information, please contact:
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Investec Bank plc 44 20 7597 5970
Patrick Robb / Sebastian Lawrence
Canaccord Genuity +44 20 7523 4606
Simon Bridges / Emma Gabriel
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Harry Staight
About Kainos
Kainos Group plc is a UK-based provider of Digital Services and
Digital Platforms.
The Group's Digital Services include full lifecycle development
and support of customised Digital Services for government and
commercial customers. Kainos is also the leading European partner
for Workday Inc. ('Workday') responsible for implementing Workday's
innovative Software-as-a-Service (SaaS) platform for enterprise
and, now, government customers.
The Group's Digital Platforms comprise specialised digital
products in the mobile healthcare and automated testing arenas.
Smart is an automated testing platform for Workday customers;
Evolve Electronic Medical Records ('EMR') is the market leading
product for the digitisation of patient notes in the Acute sector
of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based
integrated care platform for the NHS and international healthcare
providers; and Smart is an automated testing platform for Workday
customers.
Kainos has over 1,150 people across eleven offices in Europe and
the USA, working interchangeably across its Services and Platforms
divisions.
Kainos is listed on the London Stock Exchange (LSE: KNOS). For
further information, please visit www.kainos.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRQZLFLVDFXBBK
(END) Dow Jones Newswires
July 24, 2018 12:41 ET (16:41 GMT)
Kainos (LSE:KNOS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kainos (LSE:KNOS)
Historical Stock Chart
From Jul 2023 to Jul 2024
